Naseem Amin serves as Executive at Bellerophon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Naseem Amin has executed 11 insider transactions totaling $400.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 29, 2025 involved receiving (via award) 11,000 shares valued at $0.
Naseem Amin currently holds 22,000 shares of Bellerophon Therapeutics, Inc. (BLPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Naseem Amin has been a net buyer of BLPH stock. They have purchased $400.0K and sold $0 worth of shares.
Naseem Amin's most recent insider trade was on Jul 29, 2025, when they sold 11,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 7, 2023 | BLPH | $0 | Award | 47,578 | $N/A | Discretionary |
| Feb 10, 2023 | BLPH | $0 | Award | 84,000 | $N/A | Discretionary |
| Dec 31, 2021 | BLPH | $0 | Award | 39,032 | $N/A | Discretionary |
| Jan 25, 2019 | BLPH | $400.0K | Purchase | 571,429 | $0.70 | Discretionary |
| Jun 21, 2018 | BLPH | $0 | Award | 17,124 | $N/A | Discretionary |
| Sep 29, 2017 | BLPH | $0 | Purchase | 456,432 | $N/A | Discretionary |
| Jun 28, 2017 | BLPH | $0 | Award | 36,232 | $N/A | Discretionary |
| Nov 29, 2016 | BLPH | $0 | Purchase | 714,285 | $N/A | Discretionary |
| Apr 28, 2016 | BLPH | $0 | Award | 23,365 | $N/A | Discretionary |